卵巢癌女性的盆底功能障碍与性功能:系统综述
该系统综述检索MEDLINE至2020年6月,纳入18项评估卵巢癌患者尿失禁、盆腔器官脱垂、粪失禁及性功能障碍的研究。结果显示盆底功能障碍在卵巢癌治疗后常见,但发生率不高于一般人群;尿失禁和性功能障碍较肠道功能障碍更常见,性交痛和阴道干涩报告率较高。
要点
- 卵巢癌治疗前任何类型尿失禁患病率约50%,约17%报告阴道膨出感。
- 术后约半数女性有性生活,性交痛报告率40-80%,阴道干涩60-80%。
- 粪失禁术前影响4%、术后16%;盆底功能障碍发生率不高于一般人群。
核心结论
- 盆底功能障碍在卵巢癌治疗后常见,但发生率不高于一般人群。
- 尿失禁和性功能障碍的患病率高于肠道功能障碍。
- 需要更多前瞻性研究探讨妇科癌症及其治疗对盆底功能及盆底健康相关生活质量的影响。
研究设计与样本
- 系统综述,检索MEDLINE数据库截至2020年6月。
- 从360篇文章中纳入18篇:4篇评估尿失禁、2篇盆腔器官脱垂、3篇粪失禁、13篇性功能障碍。
主要发现
- 卵巢癌患者治疗前任何类型尿失禁患病率约50%,约17%报告阴道膨出感,与无癌女性相似。
- 治疗后主要尿失禁评分与无癌女性无显著差异。
- 粪失禁术前影响4%患者,术后影响16%。
- 术后约半数女性有性生活,性交痛报告率40-80%,阴道干涩60-80%。
- 部分作者发现卵巢癌患者性欲丧失问题更多、性功能评分更差,另一些作者未发现显著差异。
临床怎么用
- 应关注卵巢癌治疗后患者的尿失禁和性功能障碍,尤其性交痛和阴道干涩。
- 粪失禁在术后发生率升高,需纳入盆底功能评估。
局限性
- 盆底功能障碍研究结果高度异质性,源于定义和研究人群不同。
- 粪失禁在卵巢癌女性中研究较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pelvic floor disorders (PFD) are common conditions impacting quality of life and sexuality may worsen after ovarian cancer therapies. Our objective was to describe the prevalence of PFD and sexuality in women with ovarian cancer (OC). METHODS: We reviewed articles indexed in the MEDLINE database until June 2020 and selected articles assessing UI, POP, FI and sexual dysfunction in a population of women with OC. RESULTS: Of 360 articles, 18 were included: four assessed UI, two assessed POP, three FI, and 13 sexual dysfunction. PFD findings were highly heterogeneous due to the definitions used and the populations studied. The prevalence of any type of UI in patients with OC before treatment is around 50%, and about 17% report feeling a bulge in their vagina. These rates are similar to those reported in women without cancer. Similarly, the main post-treatment UI scores were not significantly different from women without cancer. Fecal incontinence has been less studied in women with OC but reported as affecting 4% of patients preoperatively and 16% postoperatively. About half of the women are sexually active after surgical treatment with high reported rates of dyspareunia (40-80%) and vaginal dryness (60-80%). Compared with healthy women, some authors found that OC patients had greater problems with loss of desire and poorer sexual function scores; other authors did not find a significant difference. CONCLUSIONS: While PFD seem to be common in women after treatment for OC, the rates are not higher than in the general population. Overall, there is a higher prevalence of UI and sexual dysfunction compared with bowel dysfunction. More prospective studies are needed to explore the impact of gynecologic cancers and their treatments on pelvic floor function and pelvic health-related quality of life.
引用
- Pizzoferrato AC, Klein M, Fauvet R, et al. Pelvic floor disorders and sexuality in women with ovarian cancer: A systematic review. Gynecol Oncol. 2021. PMID: 33516528. doi:10.1016/j.ygyno.2021.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。